Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01842399 · ClinicalTrials.gov registry record · Phase 1
Resveratrol and Cardiovascular Health in the Elderly
A Phase 1 study, sponsored by National Institute on Aging (NIA).
- Terminated
- Registry status
- Phase 1
- Development phase
- 73
- Enrollment target
NCT01842399 is a Phase 1 study that was terminated before completion, run by National Institute on Aging (NIA). The registered enrollment target is 73 participants.
The verdict
NCT01842399, a Phase 1 study, was terminated before completion, sponsored by National Institute on Aging (NIA).
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 73 participants
- Enrollment target
Study Summary
Background: \- Resveratrol is a compound found in the skin of red grapes. It is being tested to see if it can have positive effects on human health. Lab studies show that it may help lower blood sugar, improve heart and blood vessel health, and prevent cancer. Researchers want to test different dose levels of Resveratrol to see what kind of effects it has on older overweight people. It will be tested in healthy volunteers at least 50 years of age. Objectives: \- To test the effects of different dose levels of Resveratrol on heart and blood vessel health. Eligibility: \- Healthy overweight nonsmoking volunteers at least 50 years of age. Design: * This study will involve a screening visit and four study visits. Some of the study visits will involve overnight inpatient stays. * Participants will be screened with a physical exam and medical history. Blood and urine samples will be collected. They will be given a list of foods that they should avoid eating while on the study. * Participants will be separated into three groups. Two groups will take different dose levels of the study drug. The third group will take a placebo. * At the first study visit, participants will stay in the clinical center overnight for 2 days of tests. They will provide blood and urine samples and have body scans to measure fat and muscle mass. They will also have exercise tests. A muscle biopsy will also be performed. At this visit, they will receive their dose of the study drug. They will continue to take this dose for as long as they are on the study. * The second visit will be 16 weeks after the first one. It will take only 2 hours, and repeat most of the tests from the screening visit. * The third visit will be 16 weeks later. It will involve an overnight stay. Most of the tests from the second visit will be repeated. * The fourth and final visit will be 16 weeks later. It will involve an overnight stay. Most of the tests from the initial study visit (including the scans and the exerc
Interventions
- DRUG Placebo
- DIETARY_SUPPLEMENT Resveratrol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2015-07-14 |
| Est. Completion | 2022-12-21 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01842399
The ClinicalTrials.gov registry entry for NCT01842399 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Aging (NIA), which has 131 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01842399 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01842399 about?
NCT01842399 is a clinical study titled "Resveratrol and Cardiovascular Health in the Elderly". Background: \- Resveratrol is a compound found in the skin of red grapes. It is being tested to see if it can have positive effects on human health. Lab studies show that it may help lower blood sugar, improve heart and blood vessel health, and prevent cancer. Researchers want to test different dos...
What is the current status of trial NCT01842399?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 73 participants. The study started on 2015-07-14. Estimated completion is 2022-12-21.
What interventions are being tested in trial NCT01842399?
The interventions under investigation include: Placebo (DRUG), Resveratrol (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01842399?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.